Predictions
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.42
22.01.23
22.01.23
-
22.01.24
22.01.24
12.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
21.01.23
21.01.23
-
24.05.24
24.05.24
-
26.01.23
26.01.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€1.86
23.04.16
23.04.16
€18.58
22.10.24
22.10.24
40.44%
24.01.23
24.01.23
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.44
17.10.22
17.10.22
-
17.10.23
17.10.23
-7.41%
22.12.22
22.12.22
Risky Investment
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Canopy Growth Corp
Start price
Target price
Perf. (%)
€8.47
13.12.21
13.12.21
-
13.12.22
13.12.22
-67.06%
14.12.22
14.12.22
Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.55
13.10.22
13.10.22
€2.30
13.10.23
13.10.23
42.55%
19.11.22
19.11.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Canopy Growth Corp
Start price
Target price
Perf. (%)
€13.55
13.11.21
13.11.21
-
13.11.22
13.11.22
-69.88%
14.11.22
14.11.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Canopy Growth Corp
Start price
Target price
Perf. (%)
€2.91
03.08.22
03.08.22
€3.30
03.08.23
03.08.23
-12.37%
13.10.22
13.10.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
03.08.22
03.08.22
€2.80
03.08.23
03.08.23
-14.19%
20.09.22
20.09.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Burcon Nutrascience Corp.
Start price
Target price
Perf. (%)
€1.53
19.09.21
19.09.21
-
19.09.22
19.09.22
-75.74%
20.09.22
20.09.22
Probably not worthwhile Investment
Acasti Pharma Inc.
Start price
Target price
Perf. (%)
€11.77
12.09.21
12.09.21
€15.00
12.09.22
12.09.22
-60.64%
13.09.22
13.09.22
Could be worthwhile Investment >10% per year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€5.40
23.08.22
23.08.22
-
23.08.23
23.08.23
29.96%
09.09.22
09.09.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.85
24.08.22
24.08.22
-
24.08.23
24.08.23
-10.03%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.81
04.07.22
04.07.22
-
04.07.23
04.07.23
-24.63%
06.08.22
06.08.22
Could be worthwhile Investment >10% per year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€8.45
11.07.22
11.07.22
-
11.07.23
11.07.23
-39.77%
04.08.22
04.08.22
Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.37
28.04.22
28.04.22
€2.00
28.04.23
28.04.23
0.74%
03.08.22
03.08.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.50
11.06.22
11.06.22
€1.90
11.06.23
11.06.23
-16.96%
03.08.22
03.08.22
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Alpha Pro Tech Ltd.
Start price
Target price
Perf. (%)
€6.22
11.07.21
11.07.21
€12.00
11.07.22
11.07.22
-30.03%
12.07.22
12.07.22
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Small cyclical dependencies
Undervalued
Canopy Growth Corp
Start price
Target price
Perf. (%)
€3.50
12.06.22
12.06.22
-
12.06.23
12.06.23
-26.05%
09.07.22
09.07.22
Could be very worthwhile Investment >20% year
Emerald Health Therapeutics Inc
Start price
Target price
Perf. (%)
€0.13
08.07.21
08.07.21
-
08.07.22
08.07.22
-77.81%
08.07.22
08.07.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
08.07.21
08.07.21
-
08.07.22
08.07.22
13.98%
08.07.22
08.07.22
Sernova Corp.
Start price
Target price
Perf. (%)
€0.87
13.10.21
13.10.21
€10.00
13.10.24
13.10.24
-4.83%
15.06.22
15.06.22
Leading role in innovation
Capable Management
Good culture
Strong uniques